focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.70
Bid: 23.00
Ask: 24.40
Change: 0.20 (0.85%)
Spread: 1.40 (6.087%)
Open: 23.50
High: 23.70
Low: 23.50
Prev. Close: 23.50
TMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Contingent Consideration Shares & TVR

18 Apr 2024 10:00

RNS Number : 1721L
Mission Group PLC (The)
18 April 2024
 

18 April 2024

The Mission Group plc

("MISSION" the "Company" or the "Group")

 

Issue of Contingent Consideration Shares, Total Voting Rights

 

The MISSION Group plc (AIM: TMG), creator of Work That CountsTM, comprising a group of digital marketing and communications Agencies, provides an update on contingent consideration payments in relation to certain of the Group's past acquisitions, Influence Sports & Media ("Influence") and Mezzo Labs Ltd ("Mezzo"), first announced on 8 December 2022 and 14 February 2023 respectively, and more recently referenced in the Group's final results for the year ended 31 December 2023 on 28 March 2024.

 

Under the terms of both acquisitions, deferred consideration contingent on the financial performance of the ongoing businesses is now payable in respect of the first financial year following completion of the acquisitions (the "Contingent Consideration"). The Contingent Consideration is to be satisfied by a combination of cash and Mission shares which has been agreed between the Company and the vendors in accordance with the provisions of the underlying acquisition agreements. As such, the Company will be issuing 2,222,222 ordinary shares in aggregate to the vendors of Influence and Mezzo at the vendors' request, comprising (i) 1,000,000 existing ordinary shares held by the Company's employee benefit trust and (ii) 1,222,222 new ordinary shares in the Company to be issued at a price of 22.5 pence per share based on the Company's average share price over the 10 business days preceding 17 April 2024 (the "New Ordinary Shares").

 

Application has therefore been made for 1,222,222 New Ordinary Shares to be issued to be admitted to trading on AIM with admission expected to take place on 23 April 2024 ("Admission").

 

Following the allotment and issue of the New Ordinary Shares, there will be 92,238,119 ordinary shares in issue. The Company holds no ordinary shares in treasury and therefore this figure may be used by shareholders of the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

 

ENDS

 

 

ENQUIRIES

 

James Clifton, Chief Executive Officer

Giles Lee, Chief Financial Officer

The MISSION Group plc

 

Via Houston

 

Simon Bridges/Andrew Potts/Harry Rees

Canaccord Genuity Limited (Nominated Adviser and Broker)

020 7523 8000

 

Kate Hoare / Alexander Clelland / India Spencer

HOUSTON (Financial PR and Investor Relations)

0204 529 0549

 

 

NOTES TO EDITORS

 

MISSION is a collective of digital marketing and communications Agencies employing over 1,100 people across 25 locations and 3 continents. The Group successfully combines its diverse expertise to produce Work That Counts TM for Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real growth for some of the world's biggest brands. www.themission.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFISAAELSELL
Date   Source Headline
29th Mar 20227:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
28th Feb 20227:00 amRNSACQUISITION OF LIVITY
19th Jan 20227:00 amRNSTrading Update
11th Jan 20227:00 amRNSDirector/PDMR Shareholding
10th Jan 20221:54 pmRNSHolding(s) in Company
5th Jan 202210:07 amRNSHolding(s) in Company
17th Dec 20217:00 amRNSDirectorate Change
29th Nov 202110:16 amRNSHolding(s) in Company
25th Oct 20214:49 pmRNSHolding(s) in Company
20th Oct 20217:00 amRNSAcquisition of Soul and Trading Update
24th Sep 20217:30 amRNSHolding(s) in Company
23rd Sep 20216:10 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSInterim Results for six months to 30 June 2021
14th Jul 20217:00 amRNSTRADING UPDATE AND NOTICE OF INTERIM RESULTS
28th Jun 20217:00 amRNSGrowth Share Scheme
25th Jun 20212:17 pmRNSHolding(s) in Company
15th Jun 20217:00 amRNSDirector/PDMR Shareholding
14th Jun 20211:38 pmRNSResult of AGM
14th Jun 20217:00 amRNSTR1: Notification of Major Holdings
11th May 20219:19 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSDirectorate Changes
26th Apr 20215:05 pmRNSCorrection: Director/PDMR Shareholding
26th Apr 202112:15 pmRNSDirector/PDMR Shareholding
19th Apr 20216:04 pmRNSDirector/PDMR Shareholding
14th Apr 20217:01 amRNSFinal Results for the Year Ended 31 December 2020
14th Apr 20217:00 amRNSChanges to the Board
11th Mar 20214:40 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSHolding(s) in Company
22nd Feb 20215:37 pmRNSDirector/PDMR Shareholding
9th Feb 20219:24 amRNSDirector/PDMR Shareholding
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSTrading Update and Notice of Results
11th Nov 20204:58 pmRNSHolding(s) in Company
23rd Sep 20207:00 amRNSInterim Results
27th Jul 20207:00 amRNSACQUISITION OF INNOVATIONBUBBLE
15th Jul 20207:00 amRNSTrading Statement and Notice of Interim Results
15th Jun 20203:37 pmRNSResult of AGM
21st May 20207:00 amRNSCovid-19 and AGM Update
11th May 20204:58 pmRNSDirector Dealing and Issue of Consideration Shares
17th Apr 20203:36 pmRNSIssue of Equity
7th Apr 20205:00 pmRNSPDMR Shareholding pursuant to Growth Share Scheme
1st Apr 20207:00 amRNSFinal Results for the year ended 31 December 2019
27th Mar 20205:22 pmRNSCOVID-19 UPDATE
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
13th Mar 20202:22 pmRNSHolding(s) in Company
22nd Jan 20207:00 amRNSTrading Update
9th Dec 201911:55 amRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSLaunch of Global Competition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.